The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy

Goal Attainment Scaling
DOI: 10.1016/j.jval.2024.12.004 Publication Date: 2024-12-27T16:51:28Z